What Are Selective Serotonin Reuptake Inhibitors (SSRIs)?

Close up of Prozac, Paxil, and Zoloft antidepressant tablets
Jonathan Nourok / Getty Images
Table of Contents
View All
Table of Contents

What are the most important things I should know about SSRIs?

  • Combining SSRIs with other drugs that increase serotonin can lead to a potentially dangerous condition called serotonin syndrome.
  • Talk to your healthcare provider before taking SSRIs during pregnancy or while breastfeeding to ensure they are safe.
  • SSRIs may increase the risk of suicidal thoughts and behaviors in people under the age of 25.

Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed class of antidepressants in the United States. Developed in the 1970s, SSRIs are the first class of medication prescribed for depression.

Learn more about what SSRIs are and how they work, common brand names, and which conditions SSRIs can help treat. We also share some of the side effects of SSRIs and precautions to consider before taking this category of drugs.

How SSRIs Work

The function of SSRIs is actually described in its name—selective serotonin reuptake inhibition. Serotonin is a naturally occurring substance in the body known as a neurotransmitter. It's also known as the "feel good" chemical. Serotonin is found in the brain, central nervous system (CNS), and other parts of the body.

Serotonin has many functions, including those related to mood regulation, memory, sleep, sexual function, and digestion, among others. While serotonin is linked with feelings of happiness, low levels are connected to mood disorders like depression.

SSRIs work by blocking the reabsorption, or reuptake, of serotonin, which increases the amount of this neurotransmitter in the brain. Increasing serotonin in the brain can help regulate anxiety, improve mood, and promote a greater sense of well-being.

Common Brand Names for SSRIs

Here are the brand names of SSRIs currently approved by the U.S. Food and Drug Administration (FDA), followed by their generic drug name in parenthesis:

  • Celexa (citalopram)
  • Lexapro (escitalopram)
  • Luvox, Luvox CR (fluvoxamine)
  • Paxil, Paxil CR, Pexeva (paroxetine)
  • Prozac, Sarafem, Symbyax (fluoxetine)
  • Viibryd (vilazodone)
  • Zoloft (sertraline)

FDA-Approved SSRI Uses

In addition to treating depression, SSRIs are FDA-approved to help treat a variety of other mental health conditions in adults, including:

SSRIs are also the first-line medication option for young people with depression and anxiety. The table below lists the FDA-approved uses for individual SSRIs.

  For Children For Adults
Celexa MDD
Lexapro MDD GAD, MDD
Paxil GAD, MDD, OCD, PD, PTSD, SAD
Prozac MDD, OCD MDD, OCD, PD
Trintellix MDD
Viibryd MDD
Zoloft OCD MDD, OCD, PD, PMDD, PTSD, SAD

As you can see, not every SSRI is FDA-approved to treat every mood-related disorder.

Off-Label Uses for SSRIs

Doctors may prescribe SSRIs off-label to treat a broad range of other conditions. Among them are eating disorders, fibromyalgia, migraine headaches, and premature ejaculation.

"Off-label" refers to when a physician prescribes a medication for a purpose other than what it has been approved to treat. For example, Paxil and Zoloft are the only SSRIs approved by the FDA for PTSD, but some healthcare providers may prescribe Prozac off-label.

Prescribing a drug off-label can mean prescribing it for:

  • A different age range: Treating children with a medication that has been approved for use in adults only
  • A different condition: When a medication is used for a condition that it is not approved to treat
  • At a different dosage: When a medication is dosed differently than what has been approved

Off-label use does not imply illegal use. In fact, the practice is legal and quite common. According to one 2023 study, between 21% and 32.3% of prescriptions are written for off-label use.

Precautions and Contraindications With SSRIs

SSRIs are not for everyone and must be used with caution in certain individuals. It is important to speak to your care provider about any preexisting conditions you may have before starting an SSRI.

Pregnancy

Hundreds of studies have looked at SSRI exposure and birth defects. With the exception of Paxil, most SSRIs are generally considered safe to use during pregnancy. But they are not without risk.

Although rare, the following are risks that have been linked to SSRI use during pregnancy:

  • Birth defects: SSRI use during pregnancy may increase the risk of abdominal, heart, and lung birth defects.
  • Blood loss after childbirth: Some studies have reported a slightly higher risk of postpartum hemorrhage among women on SSRIs.
  • Miscarriage or premature birth: A person who is pregnant and taking antidepressants is at increased risk for a number of complications, including miscarriage and premature delivery.
  • Psychiatric disorders in children: Children of pregnant people who used antidepressants before and during pregnancy have a higher risk of developing a psychiatric disorder. However, this association may be attributable to the severity of the parent’s underlying condition.
  • Withdrawal symptoms in newborns: Newborns exposed to SSRIs in the last trimester may experience withdrawal symptoms such as hypoglycemia, tremors, tachycardia, rapid breathing, and respiratory distress.

Letting depression go untreated can also have a negative impact on a pregnancy. Remember to always discuss your specific situation thoroughly with your care provider before discontinuing any medication.

Breastfeeding

It's possible that SSRIs can be passed to your baby through your breastmilk. If you're pregnant (or trying to become pregnant) and wish to breastfeed, try to choose an antidepressant that is safe to use both during pregnancy and breastfeeding. 

Zoloft and Paxil have been widely studied and are considered relatively safe for use during breastfeeding. The data suggest that the amount of these drugs nursing infants are exposed to is low enough that there are no adverse effects.

Children

In 2004, the FDA issued a black box warning—the agency's strictest warning—that young people (up to age 25) taking antidepressants might experience increased suicidal thoughts and behaviors.

The warning also says that children and adolescents taking SSRIs should be carefully watched for sudden changes in their mood or actions, such as:

If you see any of these signs in your child, particularly if they are new or noticeably worse than before, talk to a healthcare provider as soon as possible.

If your child is having suicidal thoughts, contact the National Suicide Prevention Lifeline at 988 for support and assistance from a trained counselor. If you or a loved one are in immediate danger, call 911.

For more mental health resources, see our National Helpline Database.

Side Effects of SSRI Medications

SSRIs are considered the most effective antidepressants with the fewest side effects. The majority of people who take them, however, do experience at least one side effect. Most of them are minor and usually go away as your body gets used to the medication.

Common side effects of SSRIs include:

  • Diarrhea
  • Drowsiness
  • Dry mouth
  • Headache
  • Increased sweating
  • Insomnia
  • Nausea and vomiting
  • Sexual dysfunction (delayed or absent orgasm and decreased libido)
  • Weight gain
  • Anxiety

Consult with a physician so they can explain all the known side effects of your chosen SSRI. If you're experiencing one or more of these side effects, let them know. They may be able to suggest ways to lessen the effects or adjust your dose as needed.

Serotonin Syndrome

SSRIs aren't the only medications that increase serotonin levels in your body. Certain pain and migraine medications, and herbal supplements such as St. John's wort, can also increase serotonin levels. Taking two or more of these drugs (also known as serotonergic drugs) can lead to a condition called serotonin syndrome.

Serotonin syndrome can also occur if you are taking two or more antidepressants—for example, taking an SSRI and a selective norepinephrine reuptake inhibitor (SNRI) or an SSRI and monoamine oxidase inhibitor (MAOI).

If too much serotonin builds up in your body, you may experience:

  • Autonomic effects: Abnormally fast heart rate, hypertension, hyperthermia, shivering, sweating
  • Mental status effects: Confusion, delirium, excitement, restlessness, and hallucinations
  • Neuromuscular effects: Muscle twitching, tremors, and increased reflexes

Though rare, serotonin syndrome may be life-threatening if not treated immediately.

Before starting any medication, it is important that you discuss all the medications you're taking with your physician to avoid developing serotonin syndrome. You should also use caution when increasing doses of an SSRI.

Discontinuation Syndrome

SSRIs work by altering neurotransmitter levels. Neurotransmitters are the chemical messengers that attach to neurons throughout the body and influence their activity.

Neurons eventually adapt to the new level of neurotransmitters. But if the level changes too much too quickly—for example, because you've suddenly stopped taking your antidepressant—it can lead to uncomfortable withdrawal symptoms such as:

  • Feeling anxious
  • Flu-like symptoms
  • Hyperarousal
  • Nausea
  • Sensory disturbances
  • Trouble sleeping

Symptoms occur within two to four days after drug cessation and usually last one to two weeks.

As many as one in five people who stop an antidepressant quickly may experience at least a mild version of discontinuation syndrome. 

Paroxetine is linked with the highest incidence of discontinuation syndrome, whereas fluoxetine is linked with the lowest. In general, lower doses of SSRIs are associated with fewer occurrences of discontinuation syndrome.

Treatment for discontinuation syndrome depends on your individual symptoms, which SSRI you were taking, and your dosage. Recommendations for potentially lessening symptoms include tapering gradually off your dosage instead of stopping immediately, as well as switching from your current SSRI to the more slowly metabolized fluoxetine.

Discontinuation syndrome is not life-threatening and symptoms should subside within a few weeks. Talk to your physician before discontinuing your medication; they can help you develop a strategy to hopefully minimize any symptoms.

22 Sources
Verywell Mind uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. National Institutes of Health. Commonly prescribed antidepressants and how they work.

  2. Jenkins TA, Nguyen JC, Polglaze KE, Bertrand PP. Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axisNutrients. 2016;8(1):56. doi:10.3390/nu8010056

  3. Harvard Health Publishing. Serotonin: The natural mood booster.

  4. U.S. Food and Drug Administration. Selective serotonin reuptake inhibitors (SSRIs) information.

  5. Marvanova M, Gramith K. Role of antidepressants in the treatment of adults with anorexia nervosaMent Health Clin. 2018;8(3):127-137. doi:10.9740/mhc.2018.05.127

  6. Walitt B, Urrútia G, Nishishinya MB, Cantrell SE, Häuser W. Selective serotonin reuptake inhibitors for fibromyalgia syndromeCochrane Database Syst Rev. 2015;2015(6):CD011735. doi:10.1002/14651858.CD011735

  7. Burch R. Antidepressants for preventive treatment of migraineCurr Treat Options Neurol. 2019;21(4):18. doi:10.1007/s11940-019-0557-2

  8. Cayan S, Serefoğlu EC. Advances in treating premature ejaculationF1000Prime Rep. 2014;6:55. doi:10.12703/P6-55

  9. Hoskins M, Pearce J, Bethell A, et al. Pharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis. Br J Psychiatry. 2015;206(2):93-100. doi:10.1192/bjp.bp.114.148551

  10. Van Norman GA. Off-label use vs off-label marketing of drugs. JACC Basic Transl Sci. 2023;8(2):224-233. doi:10.1016/j.jacbts.2022.12.011

  11. Bérard A, Iessa N, Chaabane S, Muanda FT, Boukhris T, Zhao JP. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis. Br J Clin Pharmacol. 2015;81(4):589-604. doi:10.1111/bcp.12849

  12. Knudsen TM, Hansen AV, Garne E, Andersen A-MN. Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy--an epidemiological study using validated EUROCAT data. BMC Pregnancy Childbirth. 2014;14:333. doi:10.1186/1471-2393-14-333

  13. Bruning AHL, Heller HM, Kieviet N, et al. Antidepressants during pregnancy and postpartum hemorrhage: a systematic review. Eur J Obst Gynecol Reprod Biol. 2015;189:38-47. doi:10.1016/j.ejogrb.2015.03.022

  14. Alwan S, Friedman JM, Chambers C. Safety of selective serotonin reuptake inhibitors in pregnancy: A review of current evidence. CNS Drugs. 2016;30:499-515. doi:10.1007/s40263-016-0338-3

  15. Nordeng H, Lupattelli A, Wood M. Prenatal exposure to antidepressants and increased risk of psychiatric disorders. BMJ. 2017;358:j3950. doi:10.1136/bmj.j3950

  16. Wang J, Cosci F. Neonatal withdrawal syndrome following late in utero exposure to selective serotonin reuptake inhibitors: A systematic review and meta-analysis of observational studies. Psychother Psychosom. 2021;90(5):299-307. doi:10.1159/000516031

  17. Orsolini L, Bellantuono C. Serotonin reuptake inhibitors and breastfeeding: a systematic review. Hum Psychopharmacol Clin Exp. 2015;30(1):4-20. doi:10.1002/hup.2451

  18. U.S. Food and Drug Administration. Suicidality in children and adolescents being treated with antidepressant medications.

  19. American Academy of Child and Adolescent Psychiatry and the American Psychiatric Association. Depression: Parents' medication guide.

  20. Ramic E, Prasko S, Gavran L, Spahic E. Assessment of the antidepressant side effects occurrence in patients treated in primary careMater Sociomed. 2020;32(2):131-134. doi:10.5455/msm.2020.32.131-134

  21. Foong AL, Grindrod KA, Patel T. Demystifying serotonin syndrome (or serotonin toxicity). Can Fam Physician. 2018;64(10):720-727.

  22. Gabriel M, Sharma V. Antidepressant discontinuation syndromeCMAJ. 2017;189(21):E747. doi:10.1503/cmaj.160991

Additional Reading

By Marcia Purse
Marcia Purse is a mental health writer and bipolar disorder advocate who brings strong research skills and personal experiences to her writing.